WallStreetZenWallStreetZen

NASDAQ: NURO
Neurometrix Inc Stock

$3.69-0.03 (-0.81%)
Updated Jun 14, 2024
NURO Price
$3.69
Fair Value Price
N/A
Market Cap
$7.42M
52 Week Low
$2.70
52 Week High
$9.20
P/E
-0.59x
P/B
0.4x
P/S
1.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.27M
Earnings
-$7.98M
Gross Margin
62%
Operating Margin
-151.51%
Profit Margin
-151.5%
Debt to Equity
0.1
Operating Cash Flow
-$7M
Beta
1.02
Next Earnings
Jul 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A

NURO Overview

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NURO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NURO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NURO is good value based on its book value relative to its share price (0.4x), compared to the US Medical Devices industry average (3.87x)
P/B vs Industry Valuation
NURO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NURO due diligence checks available for Premium users.

Be the first to know about important NURO news, forecast changes, insider trades & much more!

NURO News

Valuation

NURO fair value

Fair Value of NURO stock based on Discounted Cash Flow (DCF)
Price
$3.69
Fair Value
$19.67
Undervalued by
81.24%
NURO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NURO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.59x
Industry
30.02x
Market
30.51x

NURO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.4x
Industry
3.87x
NURO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NURO's financial health

Profit margin

Revenue
$1.1M
Net Income
-$3.0M
Profit Margin
-277%
NURO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NURO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$20.7M
Liabilities
$1.9M
Debt to equity
0.1
NURO's short-term assets ($20.15M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NURO's short-term assets ($20.15M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NURO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NURO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.1M
Investing
$138.3k
Financing
$1.5M
NURO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NURO vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
NURO$7.42M-0.81%-0.59x0.40x
VVOS$7.26M-8.16%-0.21x12.48x
BTCY$8.04M-6.67%-0.50x-0.29x
NXL$6.69M-34.86%-1.36x2.87x
TBIO$8.40M+13.41%-0.18x-1.02x

Neurometrix Stock FAQ

What is Neurometrix's quote symbol?

(NASDAQ: NURO) Neurometrix trades on the NASDAQ under the ticker symbol NURO. Neurometrix stock quotes can also be displayed as NASDAQ: NURO.

If you're new to stock investing, here's how to buy Neurometrix stock.

What is the 52 week high and low for Neurometrix (NASDAQ: NURO)?

(NASDAQ: NURO) Neurometrix's 52-week high was $9.20, and its 52-week low was $2.70. It is currently -59.89% from its 52-week high and 36.67% from its 52-week low.

How much is Neurometrix stock worth today?

(NASDAQ: NURO) Neurometrix currently has 2,011,485 outstanding shares. With Neurometrix stock trading at $3.69 per share, the total value of Neurometrix stock (market capitalization) is $7.42M.

Neurometrix stock was originally listed at a price of $741,888.00 in Jul 22, 2004. If you had invested in Neurometrix stock at $741,888.00, your return over the last 19 years would have been -100%, for an annualized return of -47.41% (not including any dividends or dividend reinvestments).

How much is Neurometrix's stock price per share?

(NASDAQ: NURO) Neurometrix stock price per share is $3.69 today (as of Jun 14, 2024).

What is Neurometrix's Market Cap?

(NASDAQ: NURO) Neurometrix's market cap is $7.42M, as of Jun 16, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Neurometrix's market cap is calculated by multiplying NURO's current stock price of $3.69 by NURO's total outstanding shares of 2,011,485.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.